Navigation Links
Anthera Announces Third Quarter 2010 Financial Report and Conference Call
Date:10/26/2010

HAYWARD, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it will release its third quarter 2010 financial report after market close on Tuesday, November 2, 2010.  Anthera will host a conference call at 5 pm Eastern Time in conjunction with the release.Conference Call Access:Date:

November 2, 2010Time:

5:00 pm Eastern TimeDomestic Dial-in:

(877) 312-8807International Dial-in:

(253) 237-1190Conference ID:

19111226To access the 24-hour audio replay, U.S. and Canadian participants may dial (800) 642-1687; international participants may dial (706) 645-9291.  The conference ID for the replay is 19111226. The audio replay will be available until November 9, 2010.  This conference call will be webcast live and archived on Anthera's website until November 2, 2011, www.anthera.com.  

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has one Phase 3 clinical program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease (CAD). Anthera's Phase 2 product candidate, A-623, targets elevated levels of B-lymphocyte stimulator, or BAFF, which has been associated with a variety of B-Cell mediated autoimmune diseases, including system
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
2. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
3. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
4. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
5. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
6. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
7. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Mass. , July 31, 2014 /PRNewswire/ ... funding changes brought about by the Affordable ... reimbursement and prescribing of pharmaceutical therapies. The ... cover beneficiaries through new regulations and expanded ... occurring in the health exchanges—state-based marketplaces set ...
(Date:7/31/2014)... , July 31, 2014 Lazarus Effect, a ... interventional devices to facilitate removal of blood clots, announced ... the financing will support EU commercialization of several approved ... the Lazarus ReCover™ and Lazarus Cover™ in ... reflects investor confidence in the value of our novel, ...
(Date:7/31/2014)... COLORADO SPRINGS, Colo. , July 31, 2014 ... Company specializing in cannabis formulation-based drug development and ... has commenced production of multiple strains of cannabis ... scientific research to select the best strains for ... to bring the cannabis formulations to market for ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Lazarus Effect Closes $5 Million Financing 2Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2
... Nov. 19 A recent Reuters article reported ... expect an industry increase as a result of broader insurance ... million additional Americans may begin receiving health care insurance coverage ... on the access" extended to the new enrollees according to ...
... , NEW YORK, Nov. 19 Delcath Systems, Inc. ... Delcath Percutaneous Hepatic Perfusion (PHP(TM)) System, a minimally invasive drug ... the liver, today reported on the Company,s recent progress. , ... our team has achieved many significant milestones as we move ...
Cached Medicine Technology:Delcath Systems Reports Substantial Progress 2Delcath Systems Reports Substantial Progress 3Delcath Systems Reports Substantial Progress 4
(Date:8/1/2014)... August 01, 2014 Surftech athletes Jack ... Oahu paddleboard World Championships this past weekend in Hawaii ... 3rd place finisher Zeb Walsh were all on stock ... of the race and athletes this year were treated ... making the course extremely challenging as well as very ...
(Date:8/1/2014)... 2014 iFitDress.com, a professional company of ... collection of 2014 silver bridesmaid dresses recently. ... to the latest fashion trends. What’s more, they are ... percent off. , iFitDress.com is one of the ... not only silver bridesmaid gowns, but also many other ...
(Date:7/31/2014)... over the age of 65 face numerous barriers to ... against poverty and higher rates of asthma with worse ... of Annals of Allergy, Asthma and Immunology , ... Asthma and Immunology (ACAAI), outlines the challenges faced by ... to improve their care. , "Allergists want ...
(Date:7/31/2014)... GA (PRWEB) July 31, 2014 Developer ... camera on its Ponce City Market project in ... historic Sears, Roebuck & Company building into best-in-class office, ... completion, OxBlue reviewed Jamestown’s experience with their construction webcam ... , Jamestown wanted a construction camera ...
(Date:7/31/2014)... In today’s world, a good night’s sleep ... and sleep apnea (a medical problem where the airway collapses ... partners of the rest they need to face their daily ... and 20 million people in the United States alone have ... treated; and of those treated, many cannot tolerate their prescribed ...
Breaking Medicine News(10 mins):Health News:Surftech Bark Commander Sweeps Molokai2Oahu Stock Paddleboard Division 2Health News:iFitDress.com: Beautiful Silver Bridesmaid Dresses at Promotional Prices 2Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... ... radiography system aboard the Coast Guard Cutter HEALY (WAGB - 20) prior to its voyage ... ... of an iCR3600 computed radiography system aboard the Coast Guard Cutter HEALY (WAGB - 20) ...
... may ease pain, improve movement, study shows , SATURDAY, ... strengthen the wrist may ease the pain of tennis ... rubber bar to perform isolated eccentric wrist extensor strengthening ... and strength for one group of patients vs. another ...
... 11, 2009 The Natural Orifice Surgery Consortium ... of the American Society for Gastrointestinal Endoscopy (ASGE) ... Surgeons (SAGES), today announced Olympus, continuing commitment to ... therapy known as Natural Orifice Translumenal Endoscopic Surgery, ...
... With the two year ... provider, has seen a 70 percent increase in women booking themselves in for botox and fillers ... ... the smoking ban upon us (1st July 2009), SurgiCare, a leading UK cosmetic surgery ...
... , , TACOMA, Wash., July 10 Bridge ... that focuses on bringing life-saving dialysis to developing countries, announced ... Dialysis Center in the Philippines. Located in San Carlos, ... area, serving roughly 250,000 residents in the surrounding communities who ...
... July 10 Fitness Management Group, Inc. (the "Company"), ... announced that the Company has filed a voluntary petition ... the Bankruptcy Court for the Western District of North ... restructuring, Fuzion Investment Capital LLC, a Nevada Limited Liability ...
Cached Medicine News:Health News:iCRco Wins Government CR Contract with United States Coast Guard 2Health News:iCRco Wins Government CR Contract with United States Coast Guard 3Health News:NOSCAR increases NOTES research with Olympus Medical Systems Corporation grant 2Health News:UK Smoking Ban Fuels Rise In Surgery 2Health News:U.S. Non-Profit Announces Opening of Life-Saving Dialysis Facility in Philippines 2Health News:U.S. Non-Profit Announces Opening of Life-Saving Dialysis Facility in Philippines 3Health News:Fitness Management Group, Inc. Approves Sale of the Company 2
... is an internationally known brand famous ... The ophthalmic collection offers chic and ... creativity in titanium, metal and plastic ... unique styling with trendy shapes and ...
... The license agreement between Brook ... to 1993. Characterized by lightweight materials ... Brothers collections reflect the unique features ... brand. A product with classic style ...
... style. Creativity and cutting-edge design. Dolce & ... a new licensing agreement in October 2005.The ... 1985 by the famous designer duo, Domenico ... with their Mediterranean roots to create the ...
Michael Kors eyewear delivers chic American style, updated for today's discerning high-end consumer.,Made from the finest materials, the eyewear collection artfully mixes textures and fabrications, c...
Medicine Products: